Integra LifeSciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $415,605 | $382,653 | $442,646 | $380,834 |
Gross Profit | 209,332 | 194,432 | 249,072 | 200,238 |
EBITDA | -472,218 | -15,497 | 79,114 | 39,107 |
EBIT | -509,910 | -48,851 | 41,622 | 3,146 |
Net Income | -484,073 | -25,293 | 19,435 | -10,695 |
Net Change In Cash | 415,605 | 382,653 | 442,646 | 380,834 |
Free Cash Flow | -2,338 | -11,257 | 11,187 | -7,161 |
Cash | 217,914 | 239,104 | 246,375 | 215,157 |
Basic Shares | 76,463 | 76,463 | 77,010 | 76,448 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,610,527 | $1,541,573 | $1,557,666 | $1,542,448 |
Gross Profit | 882,061 | 888,393 | 970,311 | 944,640 |
EBITDA | 193,288 | 274,013 | 391,103 | 366,331 |
EBIT | 52,788 | 150,501 | 269,988 | 242,661 |
Net Income | -6,944 | 67,741 | 180,550 | 169,075 |
Net Change In Cash | 1,610,527 | 1,541,573 | 1,557,666 | 1,542,448 |
Cost of Revenue | -46,064 | 52,758 | ||
Free Cash Flow | 24,964 | 73,090 | 217,384 | 264,347 |
Cash | 246,375 | 276,402 | 456,661 | 513,448 |
Basic Shares | 77,010 | 80,337 | 83,516 | 85,485 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.45 |
2025-03-31 | -$0.33 |
2024-12-31 | $0.97 |
